Chetan Pujara, Ph.D Chief Research & Development Officer, SpyGlass Pharma Dr. Pujara brings extensive industry experience to ...
Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...
Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...
MUMBAI, India and WALTHAM, Mass., March 9, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...
March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...
Hampton was appointed by the Justice Department in 2019 to represent the financial interests of victims in the Purdue Pharma bankruptcy case. For two years, he served on a committee of creditors.
March 7 (Reuters) - Walgreens Boots Alliance (WBA.O), opens new tab is being taken private by Sycamore Partners for $10 billion, bringing to a close the pharmacy chain operator's nearly century ...
Pharmaceutical companies control and hide information from their clinical trials, preventing health care professionals from making the most informed decisions to best treat patients. The newly ...
US president Donald Trump has recently threatened to impose a 25% tariff on the EU, significantly escalating global trade tensions. Although these potential tariffs would impact the whole of the ...
Jazz Pharmaceuticals (JAZZ) and Chimerix (CMRX) announced the companies have entered into a definitive agreement for Jazz to acquire Chimerix for $8.55 per share in cash, representing a total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results